BRAF (V600E) mutation causes sustained BRAF kinase activity leading to constitutive activation of MAPK cascade pathway, and BRAF (V600E) mutation bearing thyroid cancer presents aggressive clinicopathologic features. The gene discussed is BRAF; the disease is thyroid gland carcinoma.